β2-agonists prevent Th1 development by selective inhibition of interleukin 12

Journal of Clinical Investigation

Volumn 100, Issue 6, 1997, Pages 1513-1519

  Panina Bordignon, Paola ^a   Mazzeo, Daniela ^a   Di Lucia, Pietro ^a   D'Ambrosio, Daniele ^a   Lang, Rosmarie ^a   Fabbri, Leonardo ^b   Self, Christopher ^c   Sinigaglia, Francesco ^a  

^a ROCHE MILANO RICERCHE   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c HOFFMANN LA ROCHE INC   (United States)

Author keywords

Cytokines; Dendritic cells; Salbutamol; T helper 2; 2 adrenoreceptor

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC AMP; INTERLEUKIN 12; SALBUTAMOL; BETA 2 ADRENERGIC RECEPTOR; BUCLADESINE; FORSKOLIN; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; OXPRENOLOL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BETA ADRENERGIC STIMULATION; DENDRITIC CELL; HELPER CELL; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; ADULT; CELL DIFFERENTIATION; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; HUMAN; MACROPHAGE; METABOLISM; TH1 CELL; TH2 CELL;

ADULT; ALBUTEROL; BUCLADESINE; CELL DIFFERENTIATION; CYCLIC AMP; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; FORSKOLIN; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; OXPRENOLOL; RECEPTORS, ADRENERGIC, BETA-2; RNA, MESSENGER; TH1 CELLS; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030612187     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119674     Document Type: Article

References (39)

1. Mosman, T.R., and R.L. Coffman. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion leads to different functional properties. Annu. Rev. Immunol. 7:145-173.
2. Abbas, A.K., K.M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature (Lond.). 383:787-793.
3. Romagnani, S. 1994. Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 12:227-257.
4. Le Gros, G., S.Z. Ben Sasson, R.A. Seder, F.D. Finkelman, and W.E. Paul. 1990. Generation of interleukin-4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4 producing cells. J. Exp. Med. 172:921-929.
5. Swain, S.L., A.D. Weinberg, M. English, and G. Huston. 1990. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145:3796-3806.
6. Paul, W.E., and R.A. Seder. 1994. Lymphocyte responses and cytokines. Cell. 76:241-251.
7. + T cells through IL-12 produced by Listeria-induced macrophages. Science (Wash. DC). 260:547-549.
8. Seder, R.A., R. Gazzinelli, A. Sher, and W.E. Paul. 1993. Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA. 90:10188-10192.
9. Manetti, R., P. Parronchi, M.G. Giudizi, M.-P. Piccinni, E. Maggi, G. Trinchieri, and S. Romagnani. 1993. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper 1 type (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177:1199-1204.
10. Rogge, L., L. Barberis-Maino, M. Biffi, N. Passini, D.H. Presky, U. Gubler, and F. Sinigaglia. 1997. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 185:1-7.
11. Kobayashi, M., L. Fitz, M. Ryan, R.M. Hewick, S.C. Clark, S. Chan, R. Loudon, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170:827-845.
12. Stern, A.S., F.J. Podlaski, J.D. Hulmes, Y.-C.E. Pan, P.M. Quinn, A.G. Wolitzky, P.C. Familletti, D.L. Stremlo, T. Truitt, R. Chizzonite, and M.K. Gately. 1990. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc. Natl. Acad. Sci. USA. 87:6808-6812.
13. van der Pouw Kraan, T.C.T.M., L.C.M. Boeije, R.J.T. Smeenk, J. Wijdenes, and L.A. Aarden. 1995. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 181:775-779.
14. Hilkens, C.M., A. Snijders, H. Vermeulen, P.M. van der Meide, E.A. Wierenga, and M.L. Kapsenberg. 1996. Accessory cell-derived IL-12 and prostaglandin E2 determine the IFNγ level of activated human CD4+ T cells. J. Immunol. 156:1722-1727.
15. Barnes, P.J. 1995. Beta-adrenergic receptors and their regulation. Am. J. Respir. Crit. Care Med. 152:838-860.
16. Lane, P., C. Burdet, F. McConnell, A. Lanzavecchia, and E. Padovan. 1995. CD40L-independent B cell activation revealed by CD40L-deficient T cell clones: evidence for distinct activation requirements for antibody formation and B cell proliferation. Eur. J. Immunol. 25:1788-1793.
17. Recalde, H.R. 1984. A simple method of obtaining monocytes in suspension. J. Immunol. Methods. 69:71-77.
18. Romani, N., D. Reider, M. Heuer, S. Ebner, E. Kampgen, B. Eibl, D. Niederwieser, and G. Schuler. 1996. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J. Immunol. Methods. 196:137-151.
19. Zhang, M., M.K. Gately, E. Wang, J. Gong, S.F. Wolf, S. Lu, R.L. Modlin, and P.F. Barnes. 1994. Interleukin 12 at the site of disease in tuberculosis. J. Clin. Invest. 93:1733-1739.
20. Gallati, H., I. Pracht, J. Schmidt, P. Haring, and G. Garotta. 1987. A simple, rapid and large capacity ELISA for biologically active and recombinant human IFN-γ. J. Biol. Regul. Homeostatic Agents. 1:109-118.
21. Buck, C., J. Brundschu, H. Gallati, P. Bartmann, and F. Pohlandt. 1994. lnterleukin-6: a sensitive parameter for the early diagnosis of neonatal bacterial infection. Pediatrics. 93:54-58.
22. Jonkman, J.H.G., H.M. Freie, W.J.V. van der Boon, and G. Grasmeijer. 1986. Single dose absorption profile and bioavailability of 2 different salbutamol tablets. Arzneimittel-Forschung. 36:1133-1135.
23. Macatonia, S., N.A. Hosken, M. Litton, P. Vieira, C.-S. Hsieh, I.A. Culpepper, M. Wysocka, G. Trinchieri, K.M. Murphy, and A. O'Garra. 1995. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J. Immunol. 154:5071-5079.
24. Heufler, C., F. Koch, U. Stanzl, G. Topar, M. Wysocka, G. Trinchieri, A. Enka, R.M. Steinman, N. Romani, and G. Schuler. 1996. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as inlerferon-γ production by T helper 1 cells. Eur. J. Immunol. 26:659-668.
25. Cella, M., D. Scheidegger, K. Palmer-Lehman, P. Lane, A. Lanzavecchia, and G. Alber. 1996. Ligation of CD40 on human dendritic cells triggers production of high levels of interleukin-12 and enhances T cell costimulatory capacity: T-T help via APC activation. Eur. J. Immunol. 184:747-752.
26. Koch, F., U. Stanzl, P. Jennewein, K. Janke, C. Heufler, E. Kampgen, N. Romani, and G. Schuler. 1996. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med. 184:741-746.
27. Manetti, R., F. Gerosa, M.G. Giudizi, R. Biagiotti, P. Parronchi, M.-P. Piccinni, S. Sampognaro, E. Maggi, S. Romagnani, and G. Trinchieri. 1994. Interleukin 12 induces stable priming for interferon γ (IFN-γ) production during differentiation of human T helper (Th) and transient IFN-γ production in established Th2 cell clones. J. Exp. Med. 179:1273-1283.
28. Severn, A., N.T. Rapson, C.A. Hunter, and F.Y. Liew. 1992. Regulation of tumor necrosis factor production by adrenaline and β-adrenergic agonists. J. Immunol. 148:3441-3445.
29. Sekut, L., B.R. Champion, K. Page, J.A. Menius, Jr., and K.M. Connolly. 1995. Anti-inflammatory activity of salmeterol: down-regulation of cytokine production. Clin. Exp. Immunol. 99:461-466.
30. Ma, X., M. Aste-Amezaga, G. Gri, F. Gerosa, and G. Trinchieri. 1997. Immunomodulalory functions and molecular regulation of IL-12. Chem. Immunol. 68:1-22.
31. Steinman, R.M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271-296.
32. Piccinni, M.P., F. Mecacci, S. Sampognaro, R. Manetti. P. Parronchi, E. Maggi, and S. Romagnani. 1993. Aeroallergen sensitization can occur during fetal life. Intl. Arch. Allergy Immunol. 102:301-303.
33. Holt, P.G., and P.D. Sly. 1997. Allergic respiratory disease: strategic targets for primary prevention during childhood. Thorax. 52:1-4.
34. Boyle, J. 1995. Beta-adrenergic agonists. Clin. Obstetr. Gynecol. 38:688-696.
35. Sheffer, A.L.E. 1995. Global strategy for asthma management and prevention. NHLBI/WHO Workshop Report. National Institutes of Health, Bethesda, MD. Publication 95-3659.
36. Baghat, R., V.A. Swystem, and D.W. Cockroft. 1996. Salbutamol-induced increase of airway responsiveness to allergen and reduced protection versus methacoline: dose response. J. Allergy Clin. Immunol. 97:47-52.
37. Abel, E.A., L.M. Di Cicco, E.K. Orenberg, J.I. Fraki, and E.M. Farber. 1986. Drugs in exacerbation of psoriasis. J. Am. Acad. Dermatol. 15:1007-1022.
38. Trembleau, S., T. Germann, M.K. Gately, and L. Adorini. 1995. The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol. Today. 16:383-386.
39. Wiegmann, K., S. Muthyala, D.K. Kim, B.G.W. Arnason, and E. Chelmicka-Schorr. 1995. Beta-adrenergic agonists suppress chronic/relapsing experimental allergic encephalomyelitis (CREAE) in Lewis rats. J. Neuroimmunol. 56:201-206.